GenOdyssee Appoints Former Chiron Executive as VP for Preclinical and Clinical Affairs | GenomeWeb

NEW YORK, June 26 – French functional genomics company GenOdyssee has appointed Jean Maral, a former Chiron Biopharmaceuticals executive, to the position of vice president and senior director of preclinical and clinical affairs, the company said Tuesday. 

In addition, Mark Hofer, an attorney with Brown Rudnick Freed and Gesmer in Boston, will join the company’s business development and marketing board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.